Breast AI


Breast AI provides solutions for breast cancer detection, measure breast density and assess personalized risk that are aimed at to optimizing efficiency, enhancing the patient experience, and improving outcomes. Arterys' Breast AI solution incorporates algorithms developed by iCAD and Therapixel.
Product specifications Information source: Vendor
Last updated: Nov. 2, 2022
Product name Breast AI
Company Arterys
Subspeciality Breast
Modality Mammography
Disease targeted Breast cancer
Key-features Lesion detection, segmentation, breast cancer risk estimation, automated breast density assessment
Suggested use Before: adapting worklist order, flagging acute findings
During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion
After: diagnosis verification
Data characteristics
Population Women at any age
Input 2D full field digital mammogram, 3D digital tomosynthesis, 2D synthetic, 3D slabs
Input format DICOM
Output Density score assessment, lesion segmentation, risk score
Output format DICOM SC, SR, GSPS
Integration Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Stand-alone third party application
Deployment Cloud-based
Trigger for analysis Automatically, right after the image acquisition
Processing time 1 - 10 minutes
Certified, Class IIa , MDD/MDR
510(k) cleared, Class II
Market presence
On market since 05-2022
Distribution channels
Countries present (clinical, non-research use) 5
Paying clinical customers (institutes) 10
Research/test users (institutes) 10
Pricing model Pay-per-use
Based on Number of analyses
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers